Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Transcription Factor Screening for P. falciparum Therapy

David Segal of the University of California, Davis in the U.S. will develop a high-throughput screen to search for artificial transcription factors (ATF) that are candidates to treat P. falciparum infections. ATFs could be a gene-regulating drug resource for the study and treatment of malaria.

More information about Apply Synthetic Biology to Global Health Challenges (Round 8)